Skip to main content
. 2023 Nov 13;113(2):301–312. doi: 10.1007/s00392-023-02327-9

Table 5.

Univariable Cox regression for log2(NLR)

Outcome Number of events Estimated hazard ratio (95% CI) p value
Overall CTR-CVT 50 1.443 (1.082–1.925) 0.013*
CTRCD 17 1.448 (0.799–2.626) 0.222
Myocarditis 4 5.556 (2.077–14.861)  < 0.001*
Vascular toxicity 17 1.314 (0.794–2.175) 0.288
New onset of arterial hypertension 3 1.994 (0.682–5.826) 0.207
Arrhythmia or QTc prolongation 22 1.741 (1.161–2.610) 0.007*

NLR neutrophil-to-lymphocyte ratio; CI confidence interval; CTR-CVT cancer therapy-related cardiovascular toxicity; CTRCD cancer therapy-related cardiovascular dysfunction

*Statistically significant association between NLR and outcome